This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
SB70-SSA2-SA4,87,3
1(b) The number of pharmacies, health care providers, and health plans and
2health insurance policies participating in the prescription drug importation program
3under this section.
SB70-SSA2-SA4,87,84 (c) The estimated amount of savings to residents of this state, health plans and
5health insurance policies, and employers resulting from the implementation of the
6prescription drug importation program under this section reported from the date of
7the previous report under this subsection and from the date the program was fully
8operational.
SB70-SSA2-SA4,87,109 (d) Findings of any audit functions under sub. (1) (n) completed since the date
10of the previous report under this subsection.
SB70-SSA2-SA4,87,12 11(6) Rulemaking. The commissioner may promulgate any rules necessary to
12implement this section.
SB70-SSA2-SA4,90 13Section 90. 601.59 of the statutes is created to read:
SB70-SSA2-SA4,87,14 14601.59 State-based exchange. (1) Definitions. In this section:
SB70-SSA2-SA4,87,1515 (a) “Exchange” has the meaning given in 45 CFR 155.20.
SB70-SSA2-SA4,87,1816 (b) “State-based exchange on the federal platform” means an exchange that is
17described in and meets the requirements of 45 CFR 155.200 (f) and is approved by
18the federal secretary of health and human services under 45 CFR 155.106.
SB70-SSA2-SA4,87,2219 (c) “State-based exchange without the federal platform” means an exchange,
20other than one described in 45 CFR 155.200 (f), that performs all the functions
21described in 45 CFR 155.200 (a) and is approved by the federal secretary of health
22and human services under 45 CFR 155.106.
SB70-SSA2-SA4,88,4 23(2) Establishment and operation of state-based exchange. The commissioner
24shall establish and operate an exchange that at first is a state-based exchange on
25the federal platform and then subsequently transitions to a state-based exchange

1without the federal platform. The commissioner shall develop procedures to address
2the transition from the state-based exchange on the federal platform to the
3state-based exchange without the federal platform, including the circumstances
4that shall be met in order for the transition to occur.
SB70-SSA2-SA4,88,7 5(3) Agreement with federal government. The commissioner may enter into
6any agreement with the federal government necessary to facilitate the
7implementation of this section.
SB70-SSA2-SA4,88,13 8(4) User fees. The commissioner shall impose a user fee, as authorized under
945 CFR 155.160 (b) (1), on each insurer that offers a health plan through the
10state-based exchange on the federal platform or the state-based exchange without
11the federal platform. The user fee shall be applied at one of the following rates on
12the total monthly premiums charged by an insurer for each policy under the plan for
13which enrollment is through the exchange:
SB70-SSA2-SA4,88,1514 (a) For any plan year for which the commissioner operates a state-based
15exchange on the federal platform, the rate is 0.5 percent.
SB70-SSA2-SA4,88,1916 (b) For the first 2 plan years for which the commissioner operates a state-based
17exchange without the federal platform, the rate is equal to the user fee rate the
18federal department of health and human services specifies under 45 CFR 156.50 (c)
19(1) for the federally facilitated exchanges for the applicable plan year.
SB70-SSA2-SA4,88,2220 (c) Beginning with the 3rd plan year for which the commissioner operates a
21state-based exchange without the federal platform and for each plan year thereafter,
22the rate shall be set by the commissioner by rule.
SB70-SSA2-SA4,88,24 23(5) Rules. The commissioner may promulgate rules necessary to implement
24this section.
SB70-SSA2-SA4,91
1Section 91. 601.83 (1) (h) of the statutes is renumbered 601.83 (1) (h) (intro.)
2and amended to read:
SB70-SSA2-SA4,89,83 601.83 (1) (h) (intro.) In 2019 and in each subsequent year Unless the joint
4committee on finance under s. 13.10 increases the amount upon request by the
5commissioner
, the commissioner may expend no more than $200,000,000 the
6following amounts
from all revenue sources for the healthcare stability plan under
7this section, unless the joint committee on finance under s. 13.10 has increased this
8amount upon request by the commissioner.
:
SB70-SSA2-SA4,89,12 9(he) The commissioner shall ensure that sufficient funds are available for the
10healthcare stability plan under this section to operate as described in the approval
11of the federal department of health and human services dated July 29, 2018, and in
12any waiver extension approvals
.
SB70-SSA2-SA4,92 13Section 92. 601.83 (1) (h) 1. and 3. of the statutes are created to read:
SB70-SSA2-SA4,89,1414 601.83 (1) (h) 1. In 2019, 2020, and 2021, $200,000,000.
SB70-SSA2-SA4,89,2315 3. In 2025 and in each year thereafter, the maximum expenditure amount for
16the previous year, adjusted to reflect the percentage increase, if any, in the consumer
17price index for all urban consumers, U.S. city average, for the medical care group, as
18determined by the U.S. department of labor, for the 12-month period ending on
19December 31 of the year before the year in which the amount is determined. The
20commissioner shall determine the annual adjustment amount for a particular year
21in January of the previous year. The commissioner shall publish the new maximum
22expenditure amount under this subdivision each year in the Wisconsin
23Administrative Register.
SB70-SSA2-SA4,93 24Section 93. 601.83 (1) (hm) of the statutes is renumbered 601.83 (1) (h) 2. and
25amended to read:
SB70-SSA2-SA4,90,3
1601.83 (1) (h) 2. Notwithstanding par. (h), in In 2022 and in each year
2thereafter, the commissioner may expend from all revenue sources
, 2023, and 2024,
3$230,000,000 or less for the healthcare stability plan under this section.
SB70-SSA2-SA4,94 4Section 94. 609.714 of the statutes is created to read:
SB70-SSA2-SA4,90,7 5609.714 Substance abuse counselor coverage. Limited service health
6organizations, preferred provider plans, and defined network plans are subject to s.
7632.87 (8).
SB70-SSA2-SA4,95 8Section 95. 609.719 of the statutes is created to read:
SB70-SSA2-SA4,90,11 9609.719 Coverage for telehealth services. Limited service health
10organizations, preferred provider plans, and defined network plans are subject to s.
11632.871.
SB70-SSA2-SA4,96 12Section 96. 609.83 of the statutes is amended to read:
SB70-SSA2-SA4,90,16 13609.83 Coverage of drugs and devices ; application of payments.
14Limited service health organizations, preferred provider plans, and defined network
15plans are subject to ss. 632.853, 632.861, 632.862, and 632.895 (6) (b), (16t), and
16(16v).
SB70-SSA2-SA4,97 17Section 97. 628.495 of the statutes is created to read:
SB70-SSA2-SA4,90,20 18628.495 Pharmacy benefit management broker and consultant
19licenses.
(1) Definition. In this section, “pharmacy benefit manager” has the
20meaning given in s. 632.865 (1) (c).
SB70-SSA2-SA4,90,25 21(2) License required. Beginning on the first day of the 12th month beginning
22after the effective date of this subsection .... [LRB inserts date], no individual may
23act as a pharmacy benefit management broker or consultant or any other individual
24who procures the services of a pharmacy benefit manager on behalf of a client
25without being licensed by the commissioner under this section.
SB70-SSA2-SA4,91,3
1(3) Rules. The commissioner may promulgate rules to establish criteria and
2procedures for initial licensure and renewal of licensure and to implement licensure
3under this section.
SB70-SSA2-SA4,98 4Section 98. 632.7495 (4) (b) of the statutes is amended to read:
SB70-SSA2-SA4,91,55 632.7495 (4) (b) The coverage has a term of not more than 12 3 months.
SB70-SSA2-SA4,99 6Section 99. 632.7495 (4) (c) of the statutes is amended to read:
SB70-SSA2-SA4,91,117 632.7495 (4) (c) The coverage term aggregated with all consecutive periods of
8the insurer's coverage of the insured by individual health benefit plan coverage not
9required to be renewed under this subsection does not exceed 18 6 months. For
10purposes of this paragraph, coverage periods are consecutive if there are no more
11than 63 days between the coverage periods.
SB70-SSA2-SA4,100 12Section 100. 632.7496 of the statutes is created to read:
SB70-SSA2-SA4,91,15 13632.7496 Coverage requirements for short-term plans. (1) Definition.
14In this section, “short-term, limited duration plan” means an individual health
15benefit plan described in s. 632.7495 (4).
SB70-SSA2-SA4,91,18 16(2) Guaranteed issue. An insurer that offers a short-term, limited duration
17plan shall accept every individual in this state who applies for coverage regardless
18of whether the individual has a preexisting condition.
SB70-SSA2-SA4,91,24 19(3) Prohibiting discrimination based on health status. (a) An insurer that
20offers a short-term, limited duration plan may not establish rules for the eligibility
21of any individual to enroll, or for the continued eligibility of any individual to remain
22enrolled, under a short-term, limited duration plan based on any of the following
23health status-related factors with respect to the individual or a dependent of the
24individual:
SB70-SSA2-SA4,91,2525 1. Health status.
SB70-SSA2-SA4,92,1
12. Medical condition, including both physical and mental illnesses.
SB70-SSA2-SA4,92,22 3. Claims experience.
SB70-SSA2-SA4,92,33 4. Receipt of health care.
SB70-SSA2-SA4,92,44 5. Medical history.
SB70-SSA2-SA4,92,55 6. Genetic information.
SB70-SSA2-SA4,92,76 7. Evidence of insurability, including conditions arising out of acts of domestic
7violence.
SB70-SSA2-SA4,92,88 8. Disability.
SB70-SSA2-SA4,92,169 (b) An insurer that offers a short-term, limited duration plan may not require
10any individual, as a condition of enrollment or continued enrollment under the
11short-term, limited duration plan, to pay, on the basis of any health status-related
12factor described under par. (a) with respect to the individual or a dependent of the
13individual, a premium or contribution or a deductible, copayment, or coinsurance
14amount that is greater than the premium or contribution or deductible, copayment,
15or coinsurance amount respectively for a similarly situated individual enrolled
16under the short-term, limited duration plan.
SB70-SSA2-SA4,92,19 17(4) Premium rate variation. An insurer that offers a short-term, limited
18duration plan may vary premium rates for a specific short-term, limited duration
19plan based only on the following considerations:
SB70-SSA2-SA4,92,2120 (a) Whether the short-term, limited duration plan covers an individual or a
21family.
SB70-SSA2-SA4,92,2222 (b) Rating area in the state, as established by the commissioner.
SB70-SSA2-SA4,92,2523 (c) Age, except that the rate may not vary by more than 3 to 1 for adults over
24the age groups and the age bands shall be consistent with recommendations of the
25National Association of Insurance Commissioners.
SB70-SSA2-SA4,93,1
1(d) Tobacco use, except that the rate may not vary by more than 1.5 to 1.
SB70-SSA2-SA4,93,3 2(5) Annual and lifetime limits. A short-term, limited duration plan may not
3establish any of the following:
SB70-SSA2-SA4,93,54 (a) Lifetime limits on the dollar value of benefits for an enrollee or a dependent
5of an enrollee under the short-term, limited duration plan.
SB70-SSA2-SA4,93,86 (b) Limits on the dollar value of benefits for an enrollee or a dependent of an
7enrollee under the short-term, limited duration plan for a term of coverage or for the
8aggregate duration of the short-term, limited duration plan.
SB70-SSA2-SA4,101 9Section 101. 632.76 (2) (ac) 3. (intro.) of the statutes is amended to read:
SB70-SSA2-SA4,93,1210 632.76 (2) (ac) 3. (intro.) Except as the commissioner provides by rule under
11s. 632.7495 (5), all of the following apply to an individual disability insurance policy
12that is a short-term policy, limited duration plan subject to s. 632.7495 (4) and (5):
SB70-SSA2-SA4,102 13Section 102. 632.76 (2) (ac) 3. b. of the statutes is amended to read:
SB70-SSA2-SA4,93,1914 632.76 (2) (ac) 3. b. The policy shall reduce the length of time during which a
15may not impose any preexisting condition exclusion may be imposed by the
16aggregate of the insured's consecutive periods of coverage under the insurer's
17individual disability insurance policies that are short-term policies subject to s.
18632.7495 (4) and (5). For purposes of this subd. 3. b., coverage periods are consecutive
19if there are no more than 63 days between the coverage periods
.
SB70-SSA2-SA4,103 20Section 103. 632.862 of the statutes is created to read:
SB70-SSA2-SA4,93,22 21632.862 Application of prescription drug payments. (1) Definitions. In
22this section:
SB70-SSA2-SA4,93,2323 (a) “Brand name” has the meaning given in s. 450.12 (1) (a).
SB70-SSA2-SA4,93,2424 (b) “Brand name drug” means any of the following:
SB70-SSA2-SA4,94,2
11. A prescription drug that contains a brand name and that has no generic
2equivalent.
SB70-SSA2-SA4,94,73 2. A prescription drug that contains a brand name and has a generic equivalent
4but for which the enrollee has received prior authorization from the insurer offering
5the disability insurance policy or self-insured health plan or authorization from a
6physician to obtain the prescription drug under the disability insurance policy or
7self-insured health plan.
SB70-SSA2-SA4,94,88 (c) “Disability insurance policy” has the meaning given in s. 632.895 (1) (a).
SB70-SSA2-SA4,94,99 (d) “Prescription drug” has the meaning given in s. 450.01 (20).
SB70-SSA2-SA4,94,1110 (e) “Self-insured health plan” means a self-insured health plan of the state or
11a county, city, village, town, or school district.
SB70-SSA2-SA4,94,17 12(2) Application of discounts. A disability insurance policy that offers a
13prescription drug benefit or a self-insured health plan shall apply to any calculation
14of an out-of-pocket maximum amount and to any deductible of the disability
15insurance policy or self-insured health plan for an enrollee the amount that any
16discount provided by the manufacturer of a brand name drug reduces the cost
17sharing amount charged to the enrollee for that brand name drug.
SB70-SSA2-SA4,104 18Section 104. 632.863 of the statutes is created to read:
SB70-SSA2-SA4,94,19 19632.863 Pharmaceutical representatives. (1) Definitions. In this section:
SB70-SSA2-SA4,94,2220 (a) “Health care professional” means a physician or other health care
21practitioner who is licensed to provide health care services or to prescribe
22pharmaceutical or biologic products.
SB70-SSA2-SA4,94,2423 (b) “Pharmaceutical” means a medication that may legally be dispensed only
24with a valid prescription from a health care professional.
SB70-SSA2-SA4,95,3
1(c) “Pharmaceutical representative” means an individual who markets or
2promotes pharmaceuticals to health care professionals on behalf of a pharmaceutical
3manufacturer for compensation.
SB70-SSA2-SA4,95,10 4(2) Licensure. Beginning on the first day of the 12th month beginning after
5the effective date of this subsection .... [LRB inserts date], no individual may act as
6a pharmaceutical representative in this state without being licensed by the
7commissioner as a pharmaceutical representative under this section. In order to
8obtain a license, the individual shall apply to the commissioner in the form and
9manner prescribed by the commissioner. The term of a license issued under this
10subsection is one year and is renewable.
SB70-SSA2-SA4,95,13 11(3) Display of license. A pharmaceutical representative licensed under sub.
12(2) shall display the pharmaceutical representative's license during each visit with
13a health care professional.
SB70-SSA2-SA4,95,16 14(4) Enforcement. (a) Any individual who violates this section shall be fined
15not less than $1,000 nor more than $3,000 for each offense. Each day of continued
16violation constitutes a separate offense.
SB70-SSA2-SA4,95,2017 (b) The commissioner may suspend or revoke the license of a pharmaceutical
18representative who violates this section. A suspended or revoked license may not be
19reinstated until the pharmaceutical representative remedies all violations related
20to the suspension or revocation and pays all assessed penalties and fees.
SB70-SSA2-SA4,95,23 21(5) Rules. The commissioner shall promulgate rules to implement this section,
22including rules that require pharmaceutical representatives to complete continuing
23educational coursework as a condition of licensure.
SB70-SSA2-SA4,105 24Section 105. 632.864 of the statutes is created to read:
SB70-SSA2-SA4,96,2
1632.864 Pharmacy services administrative organizations. (1)
2Definitions. In this section:
SB70-SSA2-SA4,96,33 (a) “Administrative service” means any of the following:
SB70-SSA2-SA4,96,44 1. Assisting with claims.
SB70-SSA2-SA4,96,55 2. Assisting with audits.
SB70-SSA2-SA4,96,66 3. Providing centralized payment.
Loading...
Loading...